Search Result "BCR-ABL"


Review Article

Research Status, Synthesis and Clinical Application of RecentlyMarketed and Clinical BCR-ABL Inhibitors

Journal: Current Medicinal Chemistry
Volume: 29 Issue: 1 Year: 2022 Page: 3050-3078
Author(s): Guo-Wu Rao,Wen Zhang,Yu-Jing Cao,Xiao-Liang Xu

Research Article

vHTS, 3-D Pharmacophore, QSAR and Molecular Docking Studies for the Identification of Phyto-derived ATP-Competitive Inhibitors of the BCR-ABL Kinase Domain

Journal: Current Drug Discovery Technologies
Volume: 19 Issue: 0 Year: 2022 Page: 1-9
Author(s): Idowu Olaposi Omotuyi,Olawole Yakubu Adeniran,Ayorinde Omolara Metibemu,Oluwatoba Emmanuel Oyeneyin,Damilohun Samuel Metibemu

Progress in Nitrogen and Sulphur-based Heterocyclic Compounds for their Anticancer Activity

Ebook: Key Heterocyclic Cores for Smart Anticancer Drug–Design Part II

Volume: 2 Year: 2022
Author(s):
Doi: 10.2174/9789815040043122020006
Review Article

Next-generation Bruton’s Tyrosine Kinase (BTK) Inhibitors PotentiallyTargeting BTK C481S Mutation- Recent Developments and Perspectives

Journal: Current Topics in Medicinal Chemistry
Volume: 22 Issue: 20 Year: 2022 Page: 1674-1691
Author(s):

Review Article

Lipid Engineered Nanoparticle Therapy for Burn Wound Treatment

Journal: Current Pharmaceutical Biotechnology
Volume: 23 Issue: 1 Year: 2022 Page: 1449-1459
Author(s): Abdul Qadir,Usama Ahmad,Asad Ali,Aisha Shahid,Mohd. Aqil,Nausheen Khan,Athar Ali,Waleed H. Almalki,Saad Alghamdi,Md. Abul Barkat,Sarwar Beg

Editorial free to download

Effects of Tyrosine Kinase Inhibitors on Growth and Bone Metabolism in Children with Haematologic Malignancies

Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 20 Issue: 0 Year: 2022 Page: 1-3
Author(s): Elpis Mantadakis,Athanasios Tragiannidis

Review Article

PCSK9 Inhibition-Based Therapeutic Approaches: An ImmunotherapyPerspective

Journal: Current Medicinal Chemistry
Volume: 29 Issue: 6 Year: 2022 Page: 980-999
Author(s): Amirhossein Sahebkar,Suowen Xu,Matteo Pirro,Amir Abbas Momtazi-Borojeni

Review Article

Reactive Oxygen Species (ROS): Key Components in Cancer Therapies

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 22 Issue: 2 Year: 2022 Page: 215-222
Author(s): Biswa Mohan Sahoo,Bimal Krishna Banik,Preetismita Borah,Adya Jain

Review Article

In Vitro and In Vivo Approaches for Screening the Potential of Anticancer Agents: A Review

Journal: Current Drug Discovery Technologies
Volume: 19 Issue: 0 Year: 2022 Page: 1-12
Author(s): Prem Shankar Mishra

Current Frontiers

Medicinal Attributes of Heterocyclic Compounds in Rheumatoid Arthri-tis: Recent Developments and SAR Studies

Journal: Current Topics in Medicinal Chemistry
Volume: 22 Issue: 22 Year: 2022 Page: 1821-1846
Author(s): Vikram J. Singh,Pooja A. Chawla

Previous   Next

Go To   Results 1 - 1 of 45

Filter Result

Volume Year
Content Type
Ads
© 2024 Bentham Science Publishers | Privacy Policy